Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
October 10, 2012
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach
Cecilia Mattsson, Theresa Andreasson, Nicholas Waters, et al.
Bioinformatics (Oxford, England)
|
September 21, 2019
Chordomics: a visualization tool for linking function to phylogeny in microbiomes
Kevin McDonnell, Nicholas Waters, Enda Howley, et al.
Journal of Huntington'S Disease
|
October 11, 2014
Co-administration of the Dopaminergic Stabilizer Pridopidine and Tetrabenazine in Rats
Susanna Waters, Henrik Ponten, Daniel Klamer, et al.
Behavioral and Brain Functions : BBF
|
December 6, 2006
Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder
Hans Forssberg, Elisabeth Fernell, Susanna Waters, et al.
Journal of Medicinal Chemistry
|
March 6, 2012
Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors
Fredrik Pettersson, Peder Svensson, Susanna Waters, et al.
European Journal of Medicinal Chemistry
|
January 29, 2013
Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines
Fredrik Pettersson, Peder Svensson, Susanna Waters, et al.
Journal of Medicinal Chemistry
|
February 17, 2010
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16)
Fredrik Pettersson, Henrik Pontén, Nicholas Waters, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 13, 2014
The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression
Susanna Waters, Henrik Ponten, Malin Edling, et al.
Pharmacology Research & Perspectives
|
May 21, 2021
A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers
Folke Sjöberg, Susanna Waters, Boel Löfberg, et al.
Journal of Huntington'S Disease
|
February 27, 2018
Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease
Susanna Waters, Joakim Tedroff, Henrik Ponten, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
October 10, 2012
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach
Cecilia Mattsson, Theresa Andreasson, Nicholas Waters, et al.
Bioinformatics (Oxford, England)
|
September 21, 2019
Chordomics: a visualization tool for linking function to phylogeny in microbiomes
Kevin McDonnell, Nicholas Waters, Enda Howley, et al.
Journal of Huntington'S Disease
|
October 11, 2014
Co-administration of the Dopaminergic Stabilizer Pridopidine and Tetrabenazine in Rats
Susanna Waters, Henrik Ponten, Daniel Klamer, et al.
Behavioral and Brain Functions : BBF
|
December 6, 2006
Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder
Hans Forssberg, Elisabeth Fernell, Susanna Waters, et al.
Journal of Medicinal Chemistry
|
March 6, 2012
Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors
Fredrik Pettersson, Peder Svensson, Susanna Waters, et al.
European Journal of Medicinal Chemistry
|
January 29, 2013
Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines
Fredrik Pettersson, Peder Svensson, Susanna Waters, et al.
Journal of Medicinal Chemistry
|
February 17, 2010
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16)
Fredrik Pettersson, Henrik Pontén, Nicholas Waters, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 13, 2014
The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression
Susanna Waters, Henrik Ponten, Malin Edling, et al.
Pharmacology Research & Perspectives
|
May 21, 2021
A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers
Folke Sjöberg, Susanna Waters, Boel Löfberg, et al.
Journal of Huntington'S Disease
|
February 27, 2018
Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease
Susanna Waters, Joakim Tedroff, Henrik Ponten, et al.
Page
of 3